As researchers continue to learn more about Alzheimer’s, optimism is rising that blood tests may soon assist in the clinical diagnosis of the disease and potentially help determine how it will progress in individuals.
In The Conversation, Steven DeKosky, M.D., co-deputy director of the MBI, and Todd Golde, M.D., Ph.D., executive director of the MBI, discuss the progress and challenges of Alzheimer’s diagnostics.
Click here to read their article in The Conversation.
Posted in:
MBI News